Press Releases

BiomX Appoints Merav Bassan as Chief Development Officer

Dr. Bassan Joins BiomX as the company advances into the clinic Ness Ziona, Israel – October 10, 2019, – BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced the appointment of Merav Bassan, Ph.D., as Chief...

read more

BiomX Raises $32 Million in Series B Financing

-- Proceeds will be used primarily to advance leading IBD and acne programs to the clinic -- Ness Ziona, Israel – February 20, 2019 – BiomX Ltd., a microbiome company developing customized phage therapies, today announced the closing of a $32 million...

read more

Learn More About BiomX

OUR PARTNERS